Neurotech International Limited (NTI.AX)
AUD 0.05
(-3.57%)
AUD 0.05
(-3.57%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 314.69 Thousand AUD | -76.63% |
| 2023 | 1.34 Million AUD | 127.14% |
| 2022 | 592.98 Thousand AUD | -48.19% |
| 2021 | 1.14 Million AUD | 57.4% |
| 2020 | 727.09 Thousand AUD | 104.62% |
| 2019 | 355.33 Thousand AUD | -5.41% |
| 2018 | 375.66 Thousand AUD | -42.83% |
| 2017 | 657.03 Thousand AUD | -26.43% |
| 2016 | 893.12 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 275.86 Thousand AUD | 0.0% |
| 2024 FY | 314.69 Thousand AUD | -76.63% |
| 2024 Q4 | 314.69 Thousand AUD | 0.0% |
| 2023 Q4 | 1.34 Million AUD | 0.0% |
| 2023 FY | 1.34 Million AUD | 127.14% |
| 2023 Q2 | 367.26 Thousand AUD | 0.0% |
| 2022 Q4 | 592.98 Thousand AUD | 0.0% |
| 2022 FY | 592.98 Thousand AUD | -48.19% |
| 2022 Q2 | 199.36 Thousand AUD | 0.0% |
| 2021 FY | 1.14 Million AUD | 57.4% |
| 2021 Q4 | 1.14 Million AUD | 0.0% |
| 2021 Q2 | 358.35 Thousand AUD | 0.0% |
| 2020 Q2 | 723.75 Thousand AUD | 0.0% |
| 2020 Q4 | 727.09 Thousand AUD | 0.0% |
| 2020 FY | 727.09 Thousand AUD | 104.62% |
| 2019 FY | 355.33 Thousand AUD | -5.41% |
| 2019 Q4 | 355.33 Thousand AUD | 0.0% |
| 2019 Q2 | 270.42 Thousand AUD | 0.0% |
| 2018 Q4 | 375.66 Thousand AUD | 0.0% |
| 2018 Q2 | 886.99 Thousand AUD | 0.0% |
| 2018 FY | 375.66 Thousand AUD | -42.83% |
| 2017 Q2 | 1.1 Million AUD | 0.0% |
| 2017 FY | 657.03 Thousand AUD | -26.43% |
| 2017 Q4 | 657.03 Thousand AUD | 0.0% |
| 2016 Q4 | 1.45 Million AUD | 0.0% |
| 2016 FY | 893.12 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 99.359% |
| Adherium Limited | 3.4 Million AUD | 90.763% |
| Aroa Biosurgery Limited | 14.77 Million AUD | 97.871% |
| Atomo Diagnostics Limited | 1.29 Million AUD | 75.688% |
| Anteris Technologies Ltd | 17.03 Million AUD | 98.153% |
| Control Bionics Limited | 2.75 Million AUD | 88.596% |
| CardieX Limited | 8.56 Million AUD | 96.325% |
| Compumedics Limited | 22.14 Million AUD | 98.579% |
| Cochlear Limited | 904.6 Million AUD | 99.965% |
| CleanSpace Holdings Limited | 6.94 Million AUD | 95.472% |
| Cyclopharm Limited | 13.65 Million AUD | 97.695% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | 94.232% |
| Nova Eye Medical Limited | 8.55 Million AUD | 96.32% |
| HeraMED Limited | 1.5 Million AUD | 79.103% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 98.741% |
| ImpediMed Limited | 6.24 Million AUD | 94.959% |
| InhaleRx Limited | 911.41 Thousand AUD | 65.471% |
| LBT Innovations Limited | 5.5 Million AUD | 94.287% |
| Micro-X Limited | 12.63 Million AUD | 97.509% |
| OncoSil Medical Limited | 1.98 Million AUD | 84.122% |
| PolyNovo Limited | 37.04 Million AUD | 99.15% |
| Respiri Limited | 3.55 Million AUD | 91.145% |
| SomnoMed Limited | 24.78 Million AUD | 98.73% |
| Universal Biosensors, Inc. | 10.61 Million AUD | 97.035% |
| Uscom Limited | 2.07 Million AUD | 84.823% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | 88.626% |